“People Will Pay Anything for Longevity”: How Equinox is Building to Last

Plus, investment in one’s health often begets further investment. Though the efficacy and ethics of GLP-1 drugs for users who aren’t diabetic or overweight can be debated, the fact is that over 2% of Americans are on the medication — up…